The disease was first identified in China and has since established endemic foci in Japan and South Korea, but its geographic footprint is no longer confined to East Asia. Recent detections in Southeast Asia and Africa have broadened the known range of the virus, transforming what was once considered a regional public health problem into a genuine global concern. The virus is transmitted primarily through the bite of infected ticks, although person-to-person transmission through contact with blood and bodily fluids of infected patients has been documented, adding a nosocomial dimension to the outbreak risk. Clinically, SFTS begins with high fever, fatigue, nausea, and diarrhea, accompanied by the hallmark laboratory findings of thrombocytopenia and leukopenia, but in severe cases the infection rapidly evolves into a systemic illness in which hematological, hepatic, neurological, cardiac, pulmonary, and renal injuries converge, increasingly joined by pancreatic and male reproductive tract involvement.

Central to the new review is the argument that organ injury in SFTS arises from two intertwined processes: the direct cytopathic effects of the virus on infected cells and a profoundly dysregulated host immune response that turns the body’s own defenses against its tissues. The virus enters target cells through a set of identified receptors and co-receptors, including DC-SIGN, nonmuscle myosin heavy chain IIA, C-C motif chemokine receptor 2, and lipoprotein receptor-related protein 1, a receptor repertoire that helps explain the unusually broad tissue tropism of the pathogen. Once inside, the viral nonstructural protein NSs acts as a potent antagonist of innate immunity, suppressing the type I interferon response by interfering with signaling pathways downstream of pattern recognition receptors such as RIG-I and Toll-like receptors, thereby allowing unchecked viral replication in the critical early phase of infection.

The hematological system bears the most visible brunt of the disease. Thrombocytopenia, the defining laboratory feature, results from a combination of direct viral infection of platelet progenitors and megakaryocytes, immune-mediated destruction of platelets, and consumption through disseminated intravascular coagulation, a frequent and ominous complication. The review details how viral infection of hematopoietic stem and progenitor cells suppresses platelet production at its source, while activated macrophages engaged in hemophagocytosis, a feature reminiscent of hemophagocytic lymphohistiocytosis, clear platelets and blood cells from the circulation. Prolonged activated partial thromboplastin time and thrombin time, alongside falling fibrinogen, serve as clinical markers of the coagulopathy that often precedes fatal outcomes, and the authors emphasize that disentangling production failure from peripheral destruction remains an unresolved challenge in patient management.

Neurological injury represents one of the most feared manifestations of SFTS. SFTS-associated encephalopathy and encephalitis, recognized as a distinct severe phenotype, correlates strongly with mortality, and the review assembles the evidence on how the virus reaches the central nervous system, likely through infected monocytes breaching the blood-brain barrier and through direct infection of endothelial cells that compose it. Cerebrospinal fluid findings, electroencephalographic abnormalities, and neuroimaging changes provide the clinical correlates, but the underlying immunopathology, involving activated T cells, macrophages, and a storm of inflammatory cytokines, suggests that immune-mediated damage contributes substantially to the neurological deterioration even after viral loads begin to decline.

Cardiac and pulmonary involvement further complicate the clinical course. Elevated creatine kinase-MB, troponin-I, and B-type natriuretic peptide signal myocardial injury and dysfunction that can progress to cardiogenic shock, while chest imaging revealing ground-glass opacities marks the transition toward acute respiratory distress syndrome in the most severe patients. A particularly striking association highlighted in the review is with invasive pulmonary aspergillosis, a fungal superinfection that emerges when virus-induced immunosuppression, lymphocyte depletion, and corticosteroid use converge to open the door to opportunistic pathogens. This SFTS-associated pulmonary aspergillosis carries an especially poor prognosis and underscores how the immune paralysis induced by the virus extends well beyond the antiviral response itself.

Renal injury, manifesting as acute kidney injury detected through rising serum creatinine, blood urea nitrogen, cystatin C, and beta-2 microglobulin, completes the picture of systemic organ failure. The mechanisms here combine direct viral infection of renal tubular epithelial cells, cytokine-mediated inflammation, rhabdomyolysis, and hemodynamic collapse in shock states. The review also draws attention to less widely appreciated targets of the virus, including the pancreas, where elevated amylase and lipase indicate injury that may worsen systemic inflammation, and the male reproductive tract, where evidence of viral persistence raises questions about sexual transmission that remain to be definitively answered.

On the immunological front, the review synthesizes a detailed portrait of the dysregulated response that characterizes fatal cases. Early in infection, dendritic cells and monocytes are infected and functionally impaired, while granulocytic myeloid-derived suppressor cells expand and suppress T-cell activity. Neutrophils release extracellular traps that contribute to immunothrombosis, and the T-cell compartment shows expansion of aberrant double-negative and double-positive populations alongside exhaustion markers. Proinflammatory cytokines and chemokines, including interferon gamma-induced protein 10, monocyte chemoattractant protein-1, and macrophage inflammatory protein-1 alpha, reach concentrations that correlate with disease severity and mortality. Programmed cell death pathways, including apoptosis, pyroptosis driven by gasdermin D, and necroptosis, are activated in infected tissues, releasing damage-associated molecular patterns that further amplify the inflammatory cascade in a self-perpetuating loop.

A major contribution of the review is its focus on early predictive biomarkers for organ injury, a priority for clinicians facing patients who appear stable on admission but deteriorate precipitously within days. Viral load at presentation, degree of thrombocytopenia and leukopenia, elevated liver enzymes, lactate dehydrogenase, ferritin, cytokine levels, and markers of coagulation dysfunction all carry prognostic weight, and the authors argue that combining these parameters into risk stratification algorithms could identify high-risk patients early enough for intensive intervention. Single-cell RNA sequencing and other high-dimensional approaches are beginning to reveal the cellular landscape of severe disease at unprecedented resolution, offering hope that mechanistic signatures can be translated into actionable clinical tests.

Treatment, however, remains an area of unmet need. No licensed antiviral or vaccine exists, and management is largely supportive, with ribavirin showing disappointing efficacy in clinical trials, corticosteroids and intravenous immunoglobulin producing conflicting results, and plasma exchange, continuous renal replacement therapy, and even calcium channel blockers explored as organ-protective strategies based on mechanistic rationale. The review closes by identifying the critical knowledge gaps: the precise incidence and mortality risk of each individual organ injury, the relative contribution of direct viral cytopathy versus immune-mediated damage in each organ system, and the mechanisms underlying the newly recognized pancreatic and reproductive tract involvement. As the geographic range of Bandavirus dabieense continues to expand, the authors contend that a comprehensive mechanistic understanding of organ injury is not merely an academic exercise but the essential foundation for early risk stratification and the organ-protective therapies needed to bring down a mortality rate that has remained stubbornly high for nearly two decades.

Subject of Research: Pathogenic mechanisms and clinical features of organ injury in severe fever with thrombocytopenia syndrome

Article Title: Mechanisms and clinical characteristics of organ injury in severe fever with thrombocytopenia syndrome: a comprehensive review

Article References: Han, Z., Su, K., Jin, C., Song, H., Yin, C., Lum, F.-M., & Wu, W. (2026). Mechanisms and clinical characteristics of organ injury in severe fever with thrombocytopenia syndrome: a comprehensive review. Virology Journal. https://doi.org/10.1186/s12985-026-03320-0

Image Credits: AI Generated

DOI: 10.1186/s12985-026-03320-0

Keywords: SFTS, Bandavirus dabieense, tick-borne disease, organ injury, thrombocytopenia, cytokine storm, multi-organ failure, encephalitis, acute kidney injury, biomarkers, virology, emerging infectious disease

The patient, who lived in Dalian in Liaoning Province, first noticed the bite and then, five days later, developed high fever, profound malaise and diarrhea. These early symptoms are deceptively nonspecific and mimic many common febrile illnesses circulating in the region, which is precisely what makes SFTS so dangerous in its initial phase. By the time she reached specialized care, laboratory testing revealed the two biochemical hallmarks that give the disease its name: a sharply reduced platelet count, known as thrombocytopenia, and evidence of multi-organ stress. Platelets are the cellular fragments that allow blood to clot, and their depletion can turn a routine fever into a hemorrhagic emergency. The clinical team faced a rapidly deteriorating patient whose blood was losing its ability to coagulate while her organs began to fail.

Diagnosis came on the twelfth day of illness, when metagenomic next-generation sequencing detected SFTSV genetic material in the patient’s peripheral blood. This technology represents a fundamental shift in how unexplained severe infections are identified. Rather than testing for a preselected list of suspected pathogens, metagenomic sequencing extracts all genetic material from a clinical sample and matches it against comprehensive databases, allowing previously unconsidered viruses to surface. In this case, the approach was decisive: SFTSV was not among the leading clinical suspicions when the woman was admitted, and conventional targeted tests might have missed it or delayed confirmation until it was too late to guide management. The sequencing result converted a puzzling febrile illness into a defined viral hemorrhagic syndrome with a known epidemiology.

SFTSV belongs to the genus Bandavirus within the family Phenuiviridae and was first identified in China in 2009 following outbreaks of a mysterious and often fatal febrile illness in rural communities. Since then, the virus has been documented across China and in South Korea, Japan and Vietnam, with reported case-fatality rates that range from roughly five percent to well above twenty percent in some series, depending on the population and the quality of supportive care. The principal vector is the tick, particularly Haemaphysalis longicornis, an aggressive biter that feeds on a wide range of mammals. Human infections typically occur during spring and summer, when ticks are most active and agricultural work brings people into contact with tick habitat. The virus replicates in the tick and can be transmitted through the bite, but the epidemiology has always contained puzzles that a purely tick-centered model struggles to explain.

Those puzzles center on the animal reservoir. Ticks are vectors, but the virus must circulate in vertebrate hosts for the system to persist in nature. Surveys have detected SFTSV antibodies or viral RNA in a striking variety of animals, including cattle, goats, sheep, dogs, cats, wild rodents, hedgehogs and various wild carnivores. Domestic livestock can sustain high-level viremia and are thought to amplify the virus, with ticks acquiring infection while feeding on them. Direct transmission from animals to humans has also been documented through contact with the blood or secretions of infected livestock, and person-to-person spread through contact with infected blood has occurred in hospital and funeral settings. What had not been convincingly described before this report was a scenario in which a wild mammal itself, rather than a tick feeding on it, appeared to transmit the virus directly to a human through a bite.

The Siberian weasel, Mustela sibirica, is a small, agile carnivore widespread across East and Southeast Asia, inhabiting forests, grasslands, agricultural landscapes and even the edges of towns. It is a capable hunter of rodents, which are themselves among the animals in which SFTSV has been detected, so a weasel could plausibly acquire the virus either from infected prey or from ticks carried by that prey. Weasels do bite humans, particularly when cornered, displaced from dens or drawn into conflict around poultry and livestock. In rural and semi-rural parts of northeastern China, encounters between people and these animals are not rare. If a weasel can carry SFTSV in its saliva or blood at infectious levels, a bite would provide a direct inoculation route that bypasses the tick entirely, and the five-day interval between the bite and the onset of fever in this patient is consistent with the incubation period typically observed for SFTSV.

The clinical course in this case underscores how little clinicians can currently offer once severe disease takes hold. Despite timely antiviral and supportive treatment, the patient progressed rapidly to multiple organ dysfunction and had a poor prognosis. There is no approved vaccine and no licensed specific antiviral therapy for SFTS; management rests on intensive supportive care, including fluid management, transfusion of platelets and other blood products, and organ support in critical cases. The antiviral drug ribavirin has been used, but evidence for its benefit is limited. Several candidate vaccines are in development, and experimental monoclonal antibody therapies have shown promise in early studies, but none of these tools has yet reached routine clinical practice in endemic regions. Prevention therefore depends overwhelmingly on avoiding exposure, which in turn depends on knowing exactly what the exposures are.

That is where this case report carries its greatest weight. If the weasel bite was indeed the route of infection, public health advice in endemic areas may need to expand beyond the standard warnings about tick avoidance to include caution around wild mammals, particularly small carnivores that can inflict bites. The authors of the report emphasize that the association remains unconfirmed: no animal was available for testing, so the weasel was never shown to carry the virus, and the possibility of an unrecognized tick exposure or another cryptic route cannot be entirely excluded. A single case can establish plausibility but not proof. What it does establish is a testable hypothesis, and the authors call for urgent surveillance of animal hosts in endemic regions to determine whether Mustela sibirica and other wild carnivores harbor SFTSV and whether they contribute measurably to human infections.

Surveillance of that kind would involve sampling wild and domestic animals in areas where human cases occur, testing blood and tissues for viral RNA and antibodies, and mapping the ecological relationships among ticks, reservoir mammals and human populations. Modern tools make this more feasible than it once was: metagenomic sequencing, the same technology that diagnosed this patient, can be applied to wildlife samples to reveal the full spectrum of viruses circulating in a given ecosystem. Combining that molecular surveillance with epidemiological interviews of human patients—asking systematically about animal encounters as well as tick exposure—could reveal whether bite-associated transmission is a rare curiosity or a recurring and undercounted pathway. Given the high mortality of SFTS and its expanding geographic footprint, even a modest additional transmission route would be worth detecting.

For now, the Dalian case stands as a cautionary data point at the intersection of virology, ecology and clinical medicine. It demonstrates the diagnostic power of unbiased sequencing in severe unexplained fevers, it documents the fulminant course that SFTS can take even under modern intensive care, and it widens the circle of suspected hosts to include a wild carnivore that lives in close proximity to people across much of Asia. The physicians who treated the patient, who consented to the publication of her case, frame the finding as a signal rather than a conclusion: a possible zoonotic route that demands investigation before it can be confirmed or dismissed. As climate change, land-use change and expanding human activity continue to redraw the boundaries between people, wildlife and the arthropods that connect them, cases like this one suggest that the transmission map of SFTSV may be more complicated—and the list of animals capable of passing it to humans potentially longer—than the tick-borne textbook model has assumed.

Subject of Research: A suspected zoonotic transmission of severe fever with thrombocytopenia syndrome virus via a Siberian weasel bite in China

Article Title: Severe fever with thrombocytopenia syndrome (SFTS) likely associated with a bite from a Siberian weasel (Mustela sibirica): a case report from China

Article References: Severe fever with thrombocytopenia syndrome (SFTS) likely associated with a bite from a Siberian weasel (Mustela sibirica): a case report from China. (n.d.). https://doi.org/10.1186/s12985-026-03286-z

Image Credits: AI Generated

DOI: 10.1186/s12985-026-03286-z

Keywords: SFTS, SFTSV, Siberian weasel, Mustela sibirica, zoonotic transmission, tick-borne virus, metagenomic next-generation sequencing, viral hemorrhagic fever, thrombocytopenia, China, wildlife surveillance, case report